9^th December, 2011 (Friday)

Convener: Dr Syed Mushtaq Ahmed, Srinagar

0912SIP1 Hall B (17.00 – 17.10 hrs.)

Rathore V S, Tiwari A K, Sehgal N et al. Design of DTPA-(bis amide) as AChE inhibitors for quantifying Nerve gases activity.

0912S1P2 Hall B (17.10 – 17.20 hrs.)

Mitra A, Kulkarni S, Rajeh C et al Effect of ethanol in BET Assay performed by kinetic chromogenic method for [¹⁸F] Radiopharmaceuticals other than [¹⁸F]FDG.

0912S1P3 Hall B (17.20 – 17.30 hrs.)

Shimpi H H, Nabar S J, Sonwane G A et al, 177Lu-DOTA-TATE synthesis: In house experience at RMC

0912S1P4 Hall B (17.30 – 17.40 hrs.)

Sellam K, Bal C S, Gupta D et al, Evaluation of recurrent brain tumors in low grade primary gliomas with [¹⁸F] – FDOPA PET- CT, [¹⁸F]- FDG PET –CT, ^99mTc – GHA SPECT- CT and MRI.

0912S1P5 Hall B (17.40 – 17.50 hrs.)

Ambade R N, Khan M S A, Shinde S N et al, Optimization of dry distillation method for production of 131I at pilot scale.

0912S1P6 Hall B (17.50 – 18.00 hrs.)

Hegde R, Vijaya Raj K K, Mukherjee R et al, Synthesis and radiolabeling of Rifampicin Chelate Conjugate; a possible SPECT Imaging for Infection.

0912S2P7 Hall B (18.00 – 18.10 hrs.)

Behera A, Banerjee I, De K et al, Radiosynthesis and biological evaluation of HYNIC- Tyr3Octreotide.

0912S2P8 Hall B (18.10 – 18.20 hrs.)

Sethi S K, Raunak, Sandhya R et al, Synthesis and biological evaluation of D2- receptor based ligands labeled with SPECT radionuclide for neuroendocrine tumor.

0912S2P9 Hall B (18.20 – 18.30 hrs.)

Blessy P, Anil P, Umer K et al, Experience with 68Ga DOTATOC synthesis module and imaging: Technologist perspective.

0912S2P10 Hall B (18.30 – 18.40 hrs.)

Jha A K, Zade A, Rangarajan V et al, A Software Program and Database System for GFR Estimation by Plasma Sampling method.

0912S2P11 Hall B (18.40 – 18.50 hrs.)

Santhanaraj B, Poovendiran K Analysis of teamviewer software for PET-SPECT images by Receiver Operating Characteristic Curves.

0912S2P12 Hall B (18.50 – 19.00 hrs.)

Jatale P, Asopa R, Basu S et al, Analysis of quantitative parameters and its Comparison, between physical and pharmacological stress, obtained on myocardial perfusion SPECT imaging.

0912S2P99 Hall B (19.00 – 19.10 hrs.)

Vishlavath S, Jaimini A, Tripati M et al, Application of [¹⁸F] FDG PET/CT imaging to monitor treatment response and detecting disease recurrence in tuberculosis.

0912S2P100 Hall B (19.10 – 19.20 hrs.)

Vasumathi, Rajesh K, Pandit N et al, Analysis of various types of 99Mo- ^99mTc generator systems by considering the Eluent volume, Yield and Cost effectiveness

10^th December, 2011 (Saturday)

Convener: Dr. Col JK Bhagat, Jaipur

1012S3P13 Hall A (08.00 – 08.10 hrs.)

Sahoo M K, Naswa N, Dhull V S et al, Role of [¹⁸F] FDG PET- CT in restaging of patients with recurrent malignant melanoma.

1012S3P14 Hall A (08.10 – 08.20 hrs.)

Jora C, Jacob M J, Chauhan M S et al, Dual Time Point Imaging with [¹⁸F] FDG and its comparison with MRI in primary brain tumors – A pilot Study.

1012S3P15 Hall A (08.20 – 08.30 hrs.)

Jain A, Shelly S, Indirani M et al, Assessing the diagnostic utility of [¹⁸F] FDG PET in Carcinoma of Unknown primary.

1012S3P16 Hall A (08.30 – 08.40 hrs.)

Imam S K, El- Maghraby T et al, Assessment of cancer therapy: [¹⁸F] FDG vs FLT.

1012S3P17 Hall A (08.40 – 08.50 hrs.)

Lakshmipathy KM, Deepak K A, Sureshkumar A C et al. Justification of routine WB [¹⁸F] FDG with dual phase contrast CT in Head and Neck cancers.

1012S3P18 Hall A (08.50 – 09.00 hrs.)

Sahoo S, Kand P, Basu S et al, Added advantage of ^99mTc- MDP Bone SPECT and [¹⁸F] Fluoride PET study, compared to planar bone scan in difficult cases.

10^th December, 2011 (Saturday)

Convener: Dr. N Sivaprasad, Mumbai

1012S4P19 Hall B (08.00 – 08.10 hrs.)

Gupta C, Pankaj P, Verma R et al, Role of Gallium – 68 labeled DOTANOC PET- CT in evaluation of Neuroendocrine tumour.

1012S4P20 Hall B (08.10 – 0820 hrs.)

Jain S C, Reddy A R, Impact of new ICRP recommendations on Radiation Dose from Radiopharmaceuticals to ICRP and Indian Adult.

1012S4P21 Hall B (08.20 – 08.30 hrs.)

Singh H, Patel C, Sharma G et al, Estimation of Left Ventricular function and dyssynchrony using equilibrium radionuclide angiography in patients with Right Ventricular Outflow Tract pacing – A six month follow- up study.

Competition for Shakuntala Krishnamurthy Nuclear Hepatology Award

1012S4C22 Hall B (08.30 – 08.40 hrs.)

Mukherjee R U, Ghosh S, Mangale V et al, Liver tumour imaging using a ^99mTc- labeled RGD peptide in a mouse model

1012S4C23 Hall B (08.40 – 08.50 hrs.)

Borde C R, Sundaram P S , Hepatobiliary Scintigraphy; Lighting the Right (hepatobiliary) track

1012S4C24 Hall B (08.50 – 09.00 hrs.)

Das K J, Sharma P, Singh H et al, Hybrid SPECT- CT with ^99mTc- Mebrofenin for detection and localization of Postoperative and Posttraumatic Bile leak.

1012S4C93 Hall B (09.00 – 09.10 hrs)

Arun S, Sampath S, Manohar K et al, Role of ^99mTc mebrofenin SPECT- CT in hepatobiliary scintigraphy in suspected cases of biliary leak.

1012S4C96 Hall B (09.10 – 09.20 hrs.)

Santhosh S, Sasikumar A, Kuruva M et al, Cholescintigraphy in biliary dyskinesia: a reappraisal.

11^th December, 2011 (Sunday)

Convener: Dr. Lt. Col. G. Dhananjayan, ERNAKULAM

1112S5P25 Hall A (08.00 – 08.10 hrs.)

Kaul A, Babbar A K, Attri A et al, In vitro bacterial binding assay of Scintibact (^99mTc – CAX) in isolates of Staphylococcus aureus.

1112S5P26 Hall A (08.10 – 08.20 hrs.)

Kumar A, Aijaz T, Kumaresan K, et al, Effect of Gastro- jejunostomy technique on gastric emptying in patients undergoing Whipple's surgery – Scintigraphic evaluation with liquids and solid meal.

1112S5P27 Hall A (08.20 – 08.30 hrs.)

Murari S B, Tejonath G, Ranadheer et al, Dacryoscintigraphy: A valuable tool in the management of epiphora.

1112S5C28 Hall A (08.30 – 08.40 hrs.)

Parmar M, Dutta P, Sood A et al, Role of ^99mTc DMSA(V) scintigraphy in postoperative patients with medullary thyroid carcinoma

1112S5C29 Hall A (08.40 – 08.50 hrs.)

Phykan M, Malhotra G, Asopa R et al, Prognostic impact of serial radioiodine and [¹⁸F]- FDG PET Scans in patients of advanced differentiated thyroid carcinoma.

1112S5C30 Hall A (08.50 – 09.00 hrs.)

Sahoo M K, Singhal A, Dhull V.S. et al, Role of 131I SPECT – CT as a complimentary tool to 131I diagnostic and post therapy whole body scintigraphy in management modification of differentiated thyroid carcinoma.

1112S5C31 Hall A (09.00 – 09.10 hrs.)

Bhagel NS, Rajashekharrao B, Abhyankar A et al, Estimation of late (24 hrs.) radioiodine uptake using early (2 hrs.) uptake measurement in patient of thyrotoxicosis.

1112S5C32 Hall A (09.10 – 09.20 hrs.)

Shwetal P, Lorenzo B, Catherine P et al, Thyroid Isotope Scan; Can it predict transient or permanent hypothyroidism in babies with borderline TSH values on screening test?

1112S5C33 Hall A (09.20 – 09.30 hrs.)

Gandhi S, Abhyankar A, Basu S et al, Dual malignancies in the setting of Thyroid carcinoma: Synchronous or Metachronous Nature and other variables associated with dual malignancies including impact of Radioiodine treatment on occurrence of second malignancy.

1112S5C92 Hall A (09.30 – 09.40 hrs.)

Muthu G S, Mitra S, Computation of Differential Renal Function of Ectopic Kidneys

1112S5P94 Hall A (09.40 – 09.50 hrs.)

Chakraborthy D, Bhattacharya A, Mittal B R et al Comparison of ^99mTc Methylene di phosphanate planar and SPECT / CT Bone Scan and [¹⁸F]Fluoride PET/CT bone scan in detection of skeletal metastasis in patients with carcinoma urinary bladder.

1112S5P95 Hall A (09.50 – 10.00 hrs.)

Swaroop K, Somashekarappa H M, Jayachandran et al, 14C Urea Breath Test as a diagnostic toll in Helicobacter pylori infection studies

9^th December, 2011 (Friday)

Convener: Mr. B. S. Jagadish Babu, Chennai

0912PP34 Studio 1 (14.00 – 16.00 hrs.)

Chaudhari P, Ghosh S, Nandy S et al, Initial Data from a first PET / SPECT- CT small animal imaging system and its application in the preclinical studies

0912PP35 Studio 1 (14.00 – 16.00 hrs.)

Pandey A K, Partick K, Thulkar S et al, Quality control of Kodak Dry view 8900 processor: optical density variation on the image printed on the film of size 8” × 10” and 14” × 17”

0912PP36 Studio 1 (14.00 – 16.00 hrs.)

Sharma P, Singh H, Kumar R et al, Indeterminate lesion on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT–CT.

0912PP37 Studio 1 (14.00 – 16.00 hrs.)

Bhadwal M, Singhal S, Das T et al, Preparation and preliminary biological evaluation of 177Lu- labeled porphyrin DOTA conjugate as possible tumour targeting agent.

0912PP38 Studio 1 (14.00 – 16.00 hrs.)

Singhal S, Bhadwal M, Das T et al, Preparation and preliminary biological evaluation of 90Y- labeled porphyrin DOTA conjugate as possible targeted tumour therapy.

0912PP39 Studio 1 (14.00 – 16.00 hrs.)

Tripathi M, Dhawan V, ShichunPeng et al, Comparison of Visual and ‘SPM – supported analysis of FDG- PET images for the differential diagnosis of Parkinsonian Syndromes.

0912PP40 Studio 1 (14.00 – 16.00 hrs.)

Gupta P, Tripathi M, Jaimini A et al, Comparative study between ^99mTc- ECD and [¹⁸F] FDG in evaluation of Dementia.

0912PP41 STUDIO 1 (14.00 – 16.00 hrs.)

Shimpi H H, Shruti H, Menon M D Evaluation ^99mTc- microspheres for lung deposition studies using gamma camera

0912PP42 Studio 1 (14.00 – 16.00 hrs.)

Mukherjee A, Sharma H D, Saxena S et al, Bioevaluation of BARC 125I OCU – PROSTA seeds for prostate cancer treatment.

0912PP43 Studio 1 (14.00 – 16.00 hrs.)

Sehar R, Tripathi M, D’Souza M et al, Comparison of 11C – Methionone and [¹⁸F] FDG PET imaging for brain tumour – A perspective pilot study.

0912PP44 Studio 1 (14.00 – 16.00 hrs.)

Chakraborty S, Chakravarty R, Sharma H D et al, Preparation of 68Ga – Labeled RGD Peptide dimer as a potential PET radiotracer for tumour imaging using a novel 68Ge/68Ga Generator developed in- house.

0912PP45 Studio 1 (14.00 – 16.00 hrs.)

Meena K V, Hazari P P, Khurana H et al, An antisense oligonucleotide conjugated to PET- SPECT contrast agent for in vivo imaging of 5HTIA receptor gene expression.

0912PP46 Studio 1 (14.00 – 16.00 hrs.)

Khurana H, Hazare PP, Meena V K et al, Development of ^99mTc- labeled EDTA- bis(Glutathione) for imaging GSH efflux in metastatic tumours.

0912PP47 Studio 1 (14.00 – 16.00 hrs.)

Prakash S, Hazare PP, Singh N et al, Design and synthesis of anti- integrin mAb conjugated Bismacrocyclic system for SPECT signal amplification to target β1 and β3 integrins

0912PP48 Studio 1 (14.00 – 16.00 hrs.)

Chadha N, Tiwari A K, Milton M D et al, Computational Study of Novel bis(thiosemicarbazone) analogues: Potential hypoxia imaging agents.

0912PP49 Studio 1 (14.00 – 16.00 hrs.)

Malhotra G, Potdar P, Choudhary K et al, Metabolic patterns of [¹⁸F]FDG uptake in patients of spinal tuberculosis and their comparison with MR findings

0912PP50 Studio 1 (14.00 – 16.00 hrs.)

Shivanand B, Vasumathi B, Oomen et al, Patient specific syringe fractionate unit dose model: Practicable and economic approach of cold kit fractionation in hospital radiopharmacy.

0912PP51 Studio 1 (14:00 to 16:00 hrs.)

Parghane R, Raghav K, Manohar K et al, Patterns of Salivary Scintigraphy and correlation with duration of symptoms in Sjogren's syndrome.

0912PP52 Studio 1 (14:00 to 16:00 hrs.)

Santosh K, Kaushik A, D’Souza M et al, Radiological Safety of Bone Mineral Densitometry Equipment.

0912PP53 Studio 1 (14:00 to 16:00 hrs.)

Kaushik A, Mondal A, Sharma R et al, Paediatric Dosimetry of [¹⁸F]FDG Whole Body PET/CT Scans.

0912PP54 Studio 1 (14:00 to 16:00 hrs.)

Ghai A, Mardi S, Kumar P et al, Radiopharmacy contamination in nuclear medicine – A Survey Report.

0912PP55 Studio 1 (14:00 to 16:00 hrs.)

Kumar K R, Rangarajan G K, Vinodkumar M C et al. Sentinel lymph node detection by intra operative gamma probe- An update

0912PP56 Studio 1 (14:00 to 16:00 hrs.)

Jain H, Indirani M, Shelley S et al, Diagnostic gain of SPECT- CT in skeletal scintigraphy in oncologic and non-oncologic applications.

0912PP57 Studio 1 (14:00 to 16:00 hrs.)

Behera A, Banerjee I, Kakali De et al, Synthesis, radiolabelling and biological evaluation of new somatostatin receptor positive tumour imaging agent.

0912PP58 Studio 1 (14:00 to 16:00 hrs.)

Thapa P K, Tripathi M, Jaimini A et al, Comparative study between Tc- 99m labelled Methionine and C- 11 Methionine in detection of low grade astrocytoma.

0912PP59 Studio 1 (14:00 to 16:00 hrs.)

Tripathi M, Tripathi M, Jaimini A et al, Functional neuroimaging with [¹⁸F] FDG- PET in amnestic Mild congnitive impairment.

0912PP60 Studio 1 (14:00 to 16:00 hrs.)

Soundarajan R, Naswa N, Nazar A H et al, Role of [¹⁸F]FDG PET- CT in detection of primary tumors in patients with cervical/extra cervical metastases of unknown origin.

0912PP98 Studio 1 (14:00 to 16:00 hrs.)

Baishya R, Nayak D K, Chatterjee D M Synthesis and Evaluation of ^99mTc labeled Nitriimidazoles coupled to small peptides for imaging hypoxia.

0912PP101 Studio 1 (14:00 to 16:00 hrs.)

Nayak D K, Halder K K, Baishya R et al, Synthesis and evaluation of Re and ^99mTc tricarbonyl complex of Levofloxacin as a novel infection imaging agent.

0912PP102 Studio 1 (14:00 to 16:00 hrs.)

Vimalnath K V, Shetty P, Chirayil V, et al, Preparation of 32P by Direct Neutron Activation of Red Phosphorous for the formulation of 32P[Na3PO4]

0912PP103 Studio 1 (14:00 to 16:00 hrs.)

Joshi P V, Lele V, Incidence and significance of incidental pituitary uptake on whole body FDG PET/CT scans

0912PP104 Studio1 (14:00 to 16:00 hrs.)

Chirayil V, Ambade R N, Khan M S A et al, Validation of dry distillation facility for production of multi Curie 131I in plants.

10^th December, 2011 (Saturday)

Convener: Mr. S. Subramanian, Chennai

1012PP61 Studio 1 (14:00 to 16:00 hrs.)

Goel R, Kashyap R, Manohar K et al, Utility of delayed imaging and SPECT/CT in ^99mTc labeled red blood cell scintigraphy.

1012PP62 Studio 1 (14:00 to 16:00 hrs.)

Patel R, Tiwari R et al, Usefulness of whole body FDG18 PET- CT imaging in comprehensive oncologic management- initial experience.

1012PP63 Studio 1 (14:00 to 16:00 hrs.)

Gokhale S M, Mulay A V et al, Estimation of GFR in adult Indian population: A comparison between various prediction equation using S. Creatinine, DTPA scan using Gates protocol and plasma clearance of ^99mTc- DTPA.

1012PP64 Studio 1 (14:00 to 16:00 hrs.)

Kumar K K J, Senthil R, Manohar K et al, Role of [¹⁸F] FDG- PET/CT in carcinoma penis.

1012PP65 Studio 1 (14:00 to 16:00 hrs.)

Kant K, Sharma P, Singh H et al, ^99mTc- MDP hybrid SPECT- CT for diagnosis of skull base ostemyelitis: Comparison with planar bone scintigraphy, SPECT and CT.

1012PP66 Studio 1 (14:00 to 16:00 hrs.)

Mathur M, Prasad D C, Asha P et al, 131I MIBG imaging in Pheochromocytoma - A case report.

1012PP67 Studio 1 (14:00 to 16:00 hrs.)

Santhosh S, Manohar G, Raghav K et al, [¹⁸F] FDG PET- CT in the diagnosis and follow- up of patients with Takayasu arteritis.

1012PP68 Studio 1 (14:00 to 16:00 hrs.)

Gada A, Prasad G, Mahita Y et al, Production of 68Ga DOTA- peptide using manual labeling system and 68Ge /68Ga generator – initial Indian experience of 45 runs.

1012PP69 Studio 1 (14:00 to 16:00 hrs.)

Khangembam C B, Sahoo K M, Singhal A et al, Recurrence Detection of Ewing Family of Tumors with [¹⁸F]FDG PET/CT.

1012PP70 Studio 1 (14:00 to 16:00 hrs.)

Khare A, Aggarwal V, Pande S et al, Metastases to left calf muscle from carcinoma esophagus – a rare presentation.

1012PP71 Studio 1 (14:00 to 16:00 hrs.)

Saw S. Tripathi M, D’Souza M et al, Predictive Value of FDG PET/CT scan in patients of Lung cancer for detection of extra thoracic metastasis.

1012PP72 Studio 1 (14:00 to 16:00 hrs.)

Ravina M, Jacob M J, Ray S et al, Role of high [¹⁸F] FDG uptake values with histopathological factors in primary breast cancer.

1012PP73 Studio 1 (14:00 to 16:00 hrs.)

Shimpi H H, Dand N M, Shidhaye S,S et al, radiolabeling and gamma scintigraphy of gastro- retentive nano- particels.

1012PP74 Studio 1 (14:00 to 16:00 hrs.)

Rasmi R R, Shenoy K B, Sarnaik J et al, Development of IRMA for sero- diagnosis of human C- peptide.

1012PP75 Studio 1 (14:00 to 16:00 hrs.)

Zankl C, Baumagart D, Hubner S et al, High – yielding fully- automated synthesis of [¹⁸F]fluoromethylcholine using a GE Tracer LabR MXFDG synthesizer.

1012PP76 Studio 1 (14:00 to 16:00 hrs.)

Chauhan K, Kadiyala K G, Adhikari A et al, Synthesis and biological evaluation of Thiocarbamate derivatized estradiol as SPECT Agent for ^99mTc.

1012PP77 Studio 1 (14:00 to 16:00 hrs.)

Pooja, Anjani K, Tiwari et al, Design and synthesis of neuro- catecholamine analogue and their efficiency as radiopharmaceutical.

1012PP78 Studio 1 (14:00 to 16:00 hrs.)

Adhikari A, Chauhan K, Kadiyala K G et al, Development of estradiol conjugate with macrocyclic chelate(DOA- Act- Est) as SPECT/PET radiopharmaceutical for tumor imaging.

1012PP79 Studio 1 (14:00 to 16:00 hrs.)

Kadiyala K G, Chauhan K, Adhikari A et al, Synthesis and biological evaluation of chalcone derivatives with ^99mTc as potential probe for detection of β- amyloid plagues.

1012PP80 Studio 1 (14:00 to 16:00 hrs.)

Aggarwal S, Anjani K. Tiwari et al, Design and synthesis of ^99mTc- Anthrquinone based analogues for nuclear medicine application.

1012PP81 Studio 1 (14:00 to 16:00 hrs.)

Sarika, Bhattacharya A, Kochhar R et al, Radiation exposure during leukocyte labeling process.

1012PP82 Studio 1 (14:00 to 16:00 hrs.)

Pathak C.M, Kaur B, Bhasin D K et al, Comparative performance of capsulated vs non- capsulated 14C- urea breath test for the detection of Helicobacter pylori infection.

1012PP83 Studio 1 (14:00 to 16:00 hrs.)

Saini N, Vashney R, Tiwari A.k et al, Design and synthesis of DTPA- βamyloid conjugate for SPECT imaging.

1012PP84 Studio 1 (14:00 to 16:00 hrs.)

Ponnappan A, Mathur M, Kumar S et al, “Technical issue to improve diuresis renography”.

1012PP85 Studio 1 (14:00 to 16:00 hrs.)

Sneha M, Monteiro P, Shetye B et al, PET- CT Imaging using half the recommended activity.

1012PP86 Studio 1 (14:00 to 16:00 hrs.)

Gocher K A, Tandon P et al, Radiological safety in using 13N radioisotope in the PET facility in India.

1012PP87 Studio 1 (14:00 to 16:00 hrs.)

Kaur A, Sharma S, Mittal B R et al, High radiation area survey during the running of the Cyclotron.

1012PP88 Studio 1 (14:00 to 16:00 hrs)

Kumar S Ch, Pandit N, Kumar R et al, Importance of isotope scan amongst the imaging modalities.

1012PP89 Studio 1 (14:00 to 16:00 hrs.)

Mahajan S, Tripathi M, Jaimini A et al, Comparison of ^99mTc- labeled Menthionine and 11C Menthionine radiotracer in the detection of breast carcinomas.

1012PP90 Studio 1 (14:00 to 16:00 hrs.)

Arun S, Abrar L, Sampath S et al, Role of [¹⁸F] FDG PET- CT in the evaluation of cases of renal cell carcinoma post nephrectomy.

1012PP91 Studio 1 (14.00 to 16.00 hrs.)

Gupta C, Pankaj P, Verma R et al, Role of 68Gallium labeled DOTANAC PET- CT in evaluation of Neuroendocrine tumor.

1012PP97 Studio 1 (14.00 to 16.00 hrs.)

Lakshminarayanan N, Arjun G, Rajan M G R, Preparation of 18^F – Fluoroethyltyrosine (FET): Preliminary studies